SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 12.32 |
| Enterprise Value ($M) | 12.15 |
| Book Value ($M) | -6.06 |
| Book Value / Share | -1.06 |
| Price / Book | -2.03 |
| NCAV ($M) | -7.72 |
| NCAV / Share | -1.35 |
| Price / NCAV | -1.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -3.38 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.05 |
| Current Ratio | 0.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.36 |
| Assets | 2.02 |
| Liabilities | 8.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G | Ruck Matthew J | 5.18 | ||
| 13G/A | Ness Kevin Dean | 6.25 | -16.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 19,550 | 50,827 | 38.46 | |
| 6,912 | 28,338 | 24.39 | |
| 6,976 | 35,928 | 19.42 | |
| 37,063 | 120,208 | 30.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AWH – Aspira Women's Health Inc. | AYTU – Aytu BioPharma, Inc. |
| BCDA – BioCardia, Inc. | BCTX – BriaCell Therapeutics Corp. |
| BFRG – Bullfrog AI Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io